Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-008-0137-2
Annals of Surgical Oncology 15:3244-3251 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Sasaki, Y.
Right arrow Articles by Ogawa, J.-i.
PubMed
Right arrow Articles by Sasaki, Y.
Right arrow Articles by Ogawa, J.-i.

Original Article

REG1A Expression is an Independent Factor Predictive of Poor Prognosis in Patients with Breast Cancer

Yasuhiro Sasaki, MD, Yoshihiro Minamiya, MD, PhD, Naoko Takahashi, Taku Nakagawa, MD, PhD, Yoshihisa Katayose, MD, PhD, Aki Ito, MD, Hajime Saito, MD, PhD, Satoru Motoyama, MD, PhD and Jun-ichi Ogawa, MD, PhD

Department of Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita City 010-8543, Japan

Correspondence: Address correspondence and reprint requests to: Yoshihiro Minamiya, MD, PhD; E-mail: minamiya{at}med.akita-u.ac.jp

Background: Regenerating gene I alpha (REG1A) is a growth factor known to affect pancreatic islet β cells. Although REG1A expression has also been observed in various malignant tumors, the correlation between REG1A expression and the clinicopathological characteristics of breast cancer and patient prognosis has not been evaluated.

Methods: Resected breast cancer tissues obtained at surgery from 150 breast cancer patients was stained with anti-REG1A antibody, after which the relative area occupied by stained tumor cells was evaluated under a light microscope and correlated with known clinicopathological factors.

Results: Whereas tumor cells were frequently stained with anti-REG1A antibody, cells from normal breast tissue were not stained. REG1A expression in tumors of breast cancer patients with HER2-positive disease was higher than those with HER2-negative disease (P = .0009). The 10-year disease-specific survival rate among patients with lower levels of REG1A was significantly better than among those with higher levels (P = .0002 by log rank test). Multivariate Cox proportional hazard analyses revealed REG1A (hazard ratio, 2.07; 95% confidence interval, 1.93 to 11.29; P = .0005) and axillary lymph node status (hazard ratio, 4.44; 95% confidence interval, 1.52 to 11.29; P = .0003) to be independent factors affecting the 10-year disease-specific survival rate.

Conclusion: High levels of REG1A expression within tumors are an independent predictor of poor prognosis in patients with breast cancer.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.